×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LGVN – longeveron inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LGVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
09:36 am
lgvn
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum [Yahoo! Finance]
Low
Report
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum [Yahoo! Finance]
12/3
09:15 am
lgvn
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
Low
Report
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
12/2
09:15 am
lgvn
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
Low
Report
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
12/1
12:00 pm
lgvn
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
Medium
Report
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
11/19
09:15 am
lgvn
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
Medium
Report
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
11/12
09:05 am
lgvn
Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy
Medium
Report
Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy
11/4
04:05 pm
lgvn
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
10/28
09:15 am
lgvn
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Low
Report
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
04:05 pm
LGVN
longeveron inc. - common stock
MISS
Report
-1.0%
longeveron inc. - common stock
8/13/2025
04:05 pm
LGVN
longeveron inc. - common stock
BEAT
Report
-6.8%
longeveron inc. - common stock
5/8/2025
04:05 pm
LGVN
longeveron inc. - common stock
IN-LINE
Report
-5.7%
longeveron inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
06:21 am
lgvn
Form 8-K Longeveron Inc. For: Nov 07
Low
Report
Form 8-K Longeveron Inc. For: Nov 07
11/4
04:15 pm
lgvn
Form 8-K Longeveron Inc. For: Nov 04
Low
Report
Form 8-K Longeveron Inc. For: Nov 04
11/4
04:01 pm
lgvn
Form 10-Q Longeveron Inc. For: Sep 30
Low
Report
Form 10-Q Longeveron Inc. For: Sep 30
10/27
06:00 pm
lgvn
Form 3 Longeveron Inc. For: Oct 01 Filed by: Paletta George A. Jr.
Low
Report
Form 3 Longeveron Inc. For: Oct 01 Filed by: Paletta George A. Jr.
10/27
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Oct 01 Filed by: Paletta George A. Jr.
Low
Report
Form 4 Longeveron Inc. For: Oct 01 Filed by: Paletta George A. Jr.
10/3
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Oct 01 Filed by: Powell James Nathaniel
Low
Report
Form 4 Longeveron Inc. For: Oct 01 Filed by: Powell James Nathaniel
10/3
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Oct 01 Filed by: Locklear Lisa
Low
Report
Form 4 Longeveron Inc. For: Oct 01 Filed by: Locklear Lisa
10/3
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Oct 01 Filed by: Agafonova Nataliya
Low
Report
Form 4 Longeveron Inc. For: Oct 01 Filed by: Agafonova Nataliya
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: